Literature DB >> 12828675

Standardization of FVIII & FIX assays.

T W Barrowcliffe1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12828675     DOI： 10.1046/j.1365-2516.2003.00773.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN： 1351-8216            Impact factor:   4.287


× No keyword cloud information.
  4 in total

1.  Correction of a murine model of von Willebrand disease by gene transfer.

Authors:  Robert G Pergolizzi; Guangchun Jin; Diane Chan; Lorraine Pierre; James Bussel; Barbara Ferris; Philip L Leopold; Ronald G Crystal
Journal:  Blood       Date:  2006-04-25       Impact factor: 22.113

2.  Development and evaluation of a generic population pharmacokinetic model for standard half-life factor VIII for use in dose individualization.

Authors:  Alanna McEneny-King; Pierre Chelle; Gary Foster; Arun Keepanasseril; Alfonso Iorio; Andrea N Edginton
Journal:  J Pharmacokinet Pharmacodyn       Date:  2019-05-18       Impact factor: 2.745

3.  Activity of transgene-produced B-domain-deleted factor VIII in human plasma following AAV5 gene therapy.

Authors:  Steffen Rosen; Stefan Tiefenbacher; Mary Robinson; Mei Huang; Jaydeep Srimani; Donnie Mackenzie; Terri Christianson; K John Pasi; Savita Rangarajan; Emily Symington; Adam Giermasz; Glenn F Pierce; Benjamin Kim; Stephen J Zoog; Christian Vettermann
Journal:  Blood       Date:  2020-11-26       Impact factor: 22.113

4.  Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients.

Authors:  Pierre Chelle; Cindy H T Yeung; Santiago Bonanad; Juan Cristóbal Morales Muñoz; Margareth C Ozelo; Juan Eduardo Megías Vericat; Alfonso Iorio; Jeffrey Spears; Roser Mir; Andrea Edginton
Journal:  J Pharmacokinet Pharmacodyn       Date:  2019-05-21       Impact factor: 2.745
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.